Downloads
Title
Source name
Date

Ionis to hold third quarter 2024 financial results webcast

Ionis Pharmaceuticals
23 Oct 2024

WAINZUA (eplontersen) recommended for approval in the EU by CHMP for the treatment of adults with polyneuropathy associated with hereditary transthyretin-mediated amyloidosis

Ionis Pharmaceuticals
21 Oct 2024

New positive donidalorsen data to be presented at 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting

Ionis Pharmaceuticals
03 Oct 2024

Zilganersen granted U.S. FDA Fast Track designation for people living with Alexander disease

Ionis Pharmaceuticals
01 Oct 2024
We use cookies to enhance your browsing experience. By continuing to use our website you agree to our policies Read the policyAccept